🗞️ In a UK first, researchers at @MFTnhs and @OfficialUoM are successfully identifying patients in the early, curable stages of a common liver cancer using a new, innovative test. 👇 research.cmft.nhs.uk/news-ev…

Excellent work @ChrisMysko and team. Addressing inequalities will benefit all patients.

Read our #review on #healthinequalities in #HCC published with @SpringerNature in BJCReports The first of many papers from the @REVISE_HCC study! @VSAthwal @ID_LIVER @MFT_Research @FBMH_UoM @NHSEngland @RocheDiaUK #livertwitter nature.com/articles/s44276-0…

Great discussion and took lots away from an excellent day #NHSCancerInnovation. Great to represent @MFT_Research and @FBMH_UoM and @REVISE_HCC . Also enjoyed being called an innovator!

Time for round 3 of #FGCup! Two great papers going head to head in the world of IBD! "Investigation of abnormal LFTs in patients with IBD" vs "management of chronic pain in IBD: a practical guide" fg.bmj.com/content/15/6/516 fg.bmj.com/content/15/2/144 Get your vote in! @SamanthaIBD @SoniaKSaxena @ProfChrisNorton @ChrisMysko @VSAthwal @jascott87 @sheiybani @OTavabie @dr_aditi_kumar @DrJMKennedy @DunnePdj @PhilSmithIsBack

Amazing to be shortlisted, especially for this technology that has huge potential for our patients.

🏆 Congratulations to researchers at @MFTnhs, @OfficialUoM, working in collaboration with @RocheDiaUK, who have been shortlisted for a HSJ Partnership Award 2025. The team have implemented new technology across MFT which is improving the early detection of a common liver cancer.

We have a fully funded PhD opportunity investigating how biological clocks regulate cardiac surgical outcomes for #biology, #Maths, #Chemistry. Following our recent publications in JCI and Lancet Resp Medicine. Full details: findaphd.com/phds/project/bi… @h_durrington @FBMH_UoM

Well said! Addressing these health inequalities should be a priority for any and every government.

The huge rise in deaths from liver disease exemplifies the decline of our nation's health under the Conservatives, with worsening outcomes and widening inequalities. Stockport's liver disease mortality rate is 16.5% higher than the average. I secured a debate on this crisis 👇🏾

Congratulations to all involved. Really important to have these guidelines for a group that can be ‘lost in the gap’ between adult and children’s services. Will read and re-read.

Well done @ChrisMysko Really important to understand where we are before deciding where we need to go!

Congrats to the team led by @ChrisMysko who will be taking @uk_torch forward with the project ‘Real-world hepatocellular carcinoma surveillance across the UK: a multi-centre retrospective cohort study’ - watch this space! @BSGTrainees @ScotSocGastro @WAGE_media @ulstergastro

@VSAthwal presented at #BASL2023 today on how ID LIVER is improving early detection of #LiverDisease

🔬 Exciting Findings at #EASLCongress 2023! Karen Piper Hanley presents groundbreaking research on liver fibrosis at the General Session II. Her study, titled "An Integrative Multi-omic Approach Defines Therapeutic Pathways in Liver Fibrosis," revealed promising insights into altered cell state and chromatin organisation. This innovative approach holds great potential for developing new therapeutic strategies.

Building on collaborations from @ID_LIVER to improve outcomes for people with liver disease. @sbrihealthcare

Funded (tuition and bench fees) MRes projects in @MMU_CBS, including a project with @JDHL18 and me. Help us to learn more about mechano-sensing protein networks: mmu.ac.uk/research/research-… @ManMetUni

Amazing to be one of the recipients of this programme and excited in what we can achieve! @ID_LIVER @RocheDiaUK @MFT_Research @FBMH_UoM

First @ID_LIVER quarterly meeting in person. Not a bad room @OfficialUoM !

More excellent stuff from the ID LIVER team out and about in the Research Van. #BePartofResearch @ID_LIVER